C. R. Bard

Infobox_Company
company_name = C.R. Bard, Inc.
company_
company_type = Public (NYSE|BCR)
company_slogan =
foundation = 1923
location = Murray Hill, New Jersey
key_people = Timothy M. Ring, Chairman, CEO
John H. Weiland, President, COO, Director
Todd C. Schermerhorn, SVP, CFO

num_employees = 9,400 (2006)
industry = Medical Instruments & Supplies
products =
revenue = profit$1,985.5M USD (2006)
net_income = profit$272.1M USD (2006)
homepage = [http://www.crbard.com/ www.crbard.com]

C. R. Bard, Inc. (nyse|BCR) is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialty products.

Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities.

Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall costs. [http://www.crbard.com/] , C. R. Bard, Corp Website]

History

;1907:Charles Russell Bard , an American importer of French silks, begins importing Gomenol in New York City.:Gomenol, a European cure-all, helped relieve Mr. Bard's urinary discomfort from tuberculosis.

;1923:C.R. Bard, Inc. is formally incorporated.

;1934:Davol Rubber Company, Providence Rhode Island, begins to manufacture the Foley catheter. Bard becomes the exclusive distributor for the Foley catheter and other Davol latex catheters .

;1940:Norman Jeckel develops the first American woven catheter and the machinery to manufacture it. He establishes the U.S. Catheter & Instrument Corporation (USCI) in Glens Falls, New York. Bard begins to distribute Jeckel's new catheter.

;1948:Bard moves from New York City into a new building in Summit, New Jersey.

;1958:Bard introduces a pre-sterilized packaged Foley catheter and has a sterilizer built to start handling in-plant sterilization.

;1961:Bard moves into a new one-story convert|50000|sqft|m2|sing=on building in Murray Hill, New Jersey.:Bard begins to extend its efforts beyond the urology market into cardiology, radiology and anesthesiology.

;1964:Bard establishes its first in-house manufacturing operation --- producing the molding and assembling of medical plastic tubing.:C. R. Bard Limited is formed, with headquarters and distribution located in Toronto, Canada, to handle the rising volume of Canadian business.

;1966:Bard and USCI merge, cementing a 25 year association.

;1967:Bard builds a convert|100000|sqft|m2|sing=on plant in Covington, Georgia, geographically expanding its manufacturing and warehousing operations.

;1968:Bard's capital stock is listed and traded on the New York Stock Exchange under the symbol "BCR".:Bard builds a convert|172000|sqft|m2|sing=on manufacturing plant at the Murray Hill, New Jersey location.

;1972:Bard joins with Kobayashi Pharmaceutical Company, Ltd. of Japan in establishing what is now known as Medicon, Inc., to import and market Bard products in Japan.

;1975:Bard acquires the William Harvey Research Corporation, expanding cardiopulmonary products for open-heart and bypass surgery.

;1979:Bard obtains the exclusive rights to manufacture and market the Gruntzig catheter, a balloon-tipped angioplasty catheter giving surgeons a safer and less costly alternative to open-heart surgery.

;1980:After a 46 year association, Bard acquires Davol Inc., with its Foley catheter manufacturing facilities in Moncks Corner, South Carolina and Clacton-On-Sea, England.

;1984:Bard sets up manufacturing plant in Nogales, Mexico.:Bard acquires Evermed, creating the platform for the Bard Access Systems franchise.

;1985:A joint venture, Bard Bio-Spectrum Pty. Ltd., is created in Australia.

;1988:Bard Europe is formed by merging Bard UK/Europe with USCI International.

;1989:Bard acquires Catheter Technology Corporation, Salt Lake City, Utah, strengthening Bard's position in the vascular access devices market. This becomes the divisional headquarters for Bard Access Systems, Inc. in 1991.

;1991:Bard Electrophysiology Division is formed.

;1992:Bard Bio-Spectrum Pty. Ltd. becomes Bard Australia.

;1994:Bard acquires Angiomed AG (biliary stent).:Corporate Healthcare Services organization is established.

;1996:Bard acquires IMPRA, Inc. (vascular prosthetics).:Bard Medical Division is formed.:Bard enters joint venture agreement with Pacific Health Care in Taiwan. Bard opens sales offices in China, Korea and Singapore.

;1998:Bard divests USCI cardiology division, cardiac assist & cardiopulmonary business units.:Bard acquires Dymax, Inc., an ultrasound technology for placing catheters.

;2000:Bard acquires the assets of Surgical Sense, Inc. and its Kugel® patch product line.

;2003:Bard Peripheral Vascular subsidiary is formed.:Bard acquires vacuum-assisted biopsy device technology from Biomedical Instruments and Products GmbH.:Bard acquires SourceTech Medical, L.L.C., an iodine radioactive isotope seed business for Brachytherapy.

;2004:Bard acquires assets of ONUX Medical and its Salute® fixation system for hernia and soft tissue repair.

;2005:Bard acquires assets of Genyx Medical, including the TegressT implantable bulking agent for the treatment of stress urinary incontinence.

;2006:Bard acquires Venetec International, Inc., manufacturer of the StatLock® line of catheter securement devices.

;2007:Bard celebrates 100 year milestone.2008:Bard acquires LifeStent® from Edwards Lifesciences which is marketed by Bard’s Peripheral Vascular Division, Tempe Arizona.

External links

* [http://www.crbard.com/ C. R. Bard official web site] .
* [http://finance.yahoo.com/q/pr?s=BCR Yahoo! - C. R. Bard Company Profile] .
* [http://www.answers.com/topic/c-r-bard-inc?cat=biz-fin C. R. Bard - Hoover's Profile]

Division links

* [http://www.bardaccess.com/ Bard Access Systems official web site] .

References